ANVS NOTICE: ROSEN, A RESPECTED AND LEADING LAW FIRM, Encourages Anovis Bio, Inc. Investors Who Have Suffered Losses To Obtain A Lawyer By A Important Deadline In A Class Action in securities – ANVS
NEW YORK, August 22, 2021 / PRNewswire / –
WHY: New York, New York State, August 22, 2021. Rosen Law Firm, a global investor rights law firm, reminds buyers of the securities of Annovis Bio, Inc. (NYSE American: ANVS) between May 21, 2021 and July 28, 2021, inclusive (the “Recourse Period”), October 18, 2021 lead applicant time limit.
SO WHAT: If you purchased Annovis Bio securities during the Class Period, you may be entitled to compensation without payment of any fees or additional charges through a contingency fee agreement.
WHAT TO DO NEXT: To join the Annovis Bio class action lawsuit, go to https://www.rosenlegal.com/cases-register-2148.html or call Phillip Kim, Esq. toll free at 866-767-3653 or by emailing [email protected] or [email protected] for information on the class action. A class action has already been filed. If you want to serve as the principal applicant, you must move the court not later than October 18, 2021. A principal plaintiff is a representative party acting on behalf of the other members of the class to direct the litigation.
WHY THE ROSEN LAW: We encourage investors to select qualified advisors with a track record of success in leadership roles. Often, companies providing reviews do not have comparable experience, resources or peer recognition. Be wise in choosing the right lawyer. Rosen law firm represents investors around the world, focusing its practice on class actions in securities and derivative litigation between shareholders. Rosen law firm has secured the largest securities class action settlement against a Chinese company. Rosen law firm was ranked # 1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017. The firm has been ranked in the top 4 every year since 2013 and has recovered hundreds millions of dollars for investors. In 2019 alone, the company achieved more than $ 438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as Titan of the Plaintiff’s Bar. Many of the firm’s lawyers have been recognized by Lawdragon and Super Lawyers.
CASE DETAILS: According to the lawsuit, the defendants throughout the litigation period made false and / or misleading statements and / or failed to disclose that: (1) the Company’s ANVS401 (Posiphen), a drug administered oral route which would have inhibited the synthesis of neurotoxic proteins which are the main cause of neurodegeneration, did not show statistically significant results in two patient populations with regard to factors such as orientation, judgment and resolution of problems; and (2) as a result, the defendants’ statements about its business, operations and prospects were materially false and misleading and / or lacked reasonable basis at all material times. When the real details entered the market, the lawsuit claims that investors have suffered damage.
To join the Annovis Bio class action lawsuit, go to https://www.rosenlegal.com/cases-register-2148.html or call Phillip Kim, Esq. toll free at 866-767-3653 or by emailing [email protected] or [email protected] for information on the class action.
No class has been certified. Until a group is certified, you are not represented by a lawyer unless you hire one. You can choose the lawyer of your choice. You can also remain an absent group member and do nothing at this point. The ability of an investor to participate in any potential future recovery does not depend on whether he or she is a lead applicant.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Lawyer advertising. Previous results do not guarantee a similar result.
Laurence Rosen, Esq.
Phillip Kim, Esq.
Rosen Law Firm, Pennsylvania
275 Madison Avenue, 40th Floor
New York, New York State 10016
Phone. : (212) 686-1060
Toll free: (866) 767-3653
Fax: (212) 202-3827
View original content to download multimedia:https://www.prnewswire.com/news-releases/anvs-notice-rosen-a-respected-and-leading-law-firm-encourages-annovis-bio-inc-investors-with-loss-to-secure- advice-before-important-deadline-in-classic-recourse-in-titles – anvs-301359875.html
SOURCE Rosen Law Firm, Pennsylvania